were purchased from GE Healthcare (Menlo Park, CA). Other chemicals and solvents were purchased from Aldrich (St. Louis, MO).
C-NMR spectroscopy of dicarboxylic acids at 11.7 T
Each of the compounds listed in Table 1 below was dissolved in deionized H 2 O at 250 mM along with an equal concentration of urea. None of the compounds were isotopically enriched at any position. Each solution was titrated with HCl or NaOH to pH 6.5 and pH 7.4, as measured using a standard laboratory pH meter. The solution was then transferred to a capped 5 mm NMR tube and placed inside a 37 °C temperature-regulated 500 MHz Varian INOVA spectrometer (Agilent Technologies, Palo Alto, CA) equipped with a 5 mm triple-tuned, directdetect, triple-axis gradient-equipped broadband probe (Agilent Technologies, Palo Alto, CA). 13 C NMR was performed (TR = 7 s, 28° hard pulses, 30 kHz spectral width, 60k FID points, 16-103 transients), the acquired spectra were referenced to 13 C-urea at 163.7 ppm, and the chemical shift change between 6.5 and 7.4 was measured for each 13 C nucleus. Tetramethyl succinate was not measured due to insufficient solubility in H 2 O. 
]tert-butanol (tBuOH) for hyperpolarization
Each compound in the study was formulated at the maximum concentration that formed a glassy state upon immediate immersion in liquid nitrogen. Formulation glassing was determined by visual inspection; if the flashfrozen formulation without radical added was transparent, then it was determined to be in a glassy state. All formulations were made with the isotopically enriched molecules of interest.
[2-13 C,D 10 ]DEMA 225.5 mg of [2-13 C,D 10 ]diethylmalonic acid (DEMA) were added to 225.2 mg of N,N-dimethylacetamide, vortexed to mix, and spun down in a microcentrifuge. The mixture was sonicated for 10 minutes at 37 °C, 7.3 mg of OX063 trityl radical were added, and after vortexing and spinning down the solution was sonicated for another 8-9 minutes at 37 °C. To 300 μL of the resulting formulation was added 1.2 uL of 500 mM Gd-DOTA (Guerbet, Bloomington, IN). The final concentration of DEMA in the formulation was ~3.8 M.
[2-13 C,D 4 ]CDPA 29.9 mg of [2-13 C,D 4 ]cyclopropane-1,1-dicarboxylic acid (CPDA) were added to 32.8 mg of dimethyl sulfoxide, vortexed to mix, and spun down in a microcentrifuge. The mixture was sonicated at room temperature until fully dissolved. 1.3 mg of OX063 trityl radical were added, and after vortexing and spinning down the solution was sonicated again until fully dissolved. The final concentration of CPDA in the formulation was ~4.0 M.
[1-13 C,D 9 ]tBuOH Tert-butanol was formulated as previously described. [5] Briefly, 500 uL each of [1-13 C,D 9 ]tert-butanol and glycerol were mixed together, and 16.0 mg of Finland trityl radical were dissolved with sonication. Gd-DOTA was added to a final concentration of 1 mM. Figure 3c , the chemical shift separation between DEMA and tBuOH changed 0.04 ± 0.02 ppm from the 1 st to 50 th timepoints, resulting in a measured pH difference of 0.03 ± 0.02 unit between the two timepoints. Peak areas from the hyperpolarized spectra were flip angle-corrected and fit to a decaying exponential to approximate T 1 values. The polarization was determined with reference to a spectrum at thermal equilibrium (TR = 5 * [measured T 1 ], 90° hard pulse, same spectral window/resolution, 16-64 transients), accounting for differences in flip angle and the transfer time between the polarizer and spectrometer.
C-NMR titration

HP [2-13 C,D 4 ]CPDA
For the HP CPDA experiments, only T 1 was measured. 10 μL of formulated compound were placed in a sample cup and polarized at 94.075 GHz at a temperature of 1.3-1.4 K for 30 minutes using a HyperSense DNP polarizer. The sample was then dissolved using 4-4.3 mL of 0.3 mM EDTA solution and ejected into a glass flask containing 380-420 μL of 0.1 M NaOH to neutralize the compound (pH between 6.6 and 6.8). The dissolution and NMR protocol used was identical to that used with HP DEMA, described in the preceding section.
HP DEMA T 1 fluctuation with pH over the physiologic rangeFigure S1 presents the DEMA T 1 measured during HP 13 C NMR as a function of dissolution pH (n = 3). The T 1 fluctuation was less than 10% across all pH values measured. As such, the T 1 value presented in the manuscript is the average ± s.d. of these three measurements. 
HP phantom imaging for pH quantification at 3 T
75 μL each of [2-13 C,D 10 ]DEMA and tBuOH formulations were polarized, as described previously, and dissolved using 5 mL of 0.3 mM EDTA solution. ~1 mL of HP solution was added to each of five 15 mL NMR tubes filled with 14 mL of water and NaOH at various concentrations. The final DEMA concentration in each tube was ~4 mM. Tubes were kept at 37 just prior to dissolution. The tubes were briefly vortexed to mix and inserted into a ℃ 3 T clinical imaging system (GE Healthcare, Milwaukee, WI) equipped with a custom-built 8 mm 13 C solenoid coil. The system was tuned and shimmed prior to HP imaging, and a T 2 -weighted 1 H spin-echo axial image of the five tubes was acquired for co-registration with the 13 C data. The 13 C transmitter frequency for HP DEMA imaging was calculated using a 13 C-urea phantom. The transfer time between the polarizer and the magnet was ~1 minute. The pulse sequence was a 13 C 2D CSI sequence (10 x 10 x 2048 matrix size, centric encoding, 10° hard pulses, FOV = 75 x 75 mm, 25 kHz spectral width, TR = 105 ms, total imaging time = 10.5 s). After imaging, the pH of each tube in the phantom was measured at 37 outside the magnet using a conventional pH electrode (Ion ℃ 500 series, Oakton Instruments, Vernon Hills, IL) to compare with the pH measured via spectroscopy. Shortly after imaging, the DEMA T 1 was measured at 3 T with the remaining HP magnetization via 13 C NMR spectroscopy (10° hard pulses, TR = 3 s).
The HP data were Fourier-transformed and visualized using an open-source software, SIVIC (Sourceforge.net). The voxel grid was shifted ½ voxel to the left by applying a linear phase factor along the horizontal direction. The chemical shift differences per voxel between DEMA and tBuOH were used for analysis. Spectra with a DEMA or tBuOH SNR ≤ 5 were excluded from analysis.
